Superior Tumor Cell Uptake by Mono- and Tri-Nuclear Rhodamine-Gadolinium(III) Agents

Area of Science:

• Inorganic Chemistry
• Materials Science
• Biomedical Imaging

Background:

• Gadolinium(III) complexes are widely used as contrast agents in Magnetic Resonance Imaging (MRI).
• Rhodamine derivatives have shown potential in biological imaging due to their fluorescent properties.
• Developing targeted imaging agents with improved cellular uptake and selectivity is crucial for early disease detection.

Purpose of the Study:

• To synthesize and characterize novel trinuclear and mononuclear rhodamine-Gd(III) complexes.
• To evaluate the selectivity and cytotoxicity of these complexes in human glioma and glial cell lines.
• To compare the tumor cell uptake efficiency of the novel complexes with existing delocalized lipophilic cations.

Main Methods:

• Synthesis of novel trinuclear and mononuclear rhodamine-Gd(III) complexes.
• Characterization using spectroscopic and analytical techniques.
• In vitro evaluation of cellular uptake, selectivity, and cytotoxicity in T98G (glioma) and SVG p12 (glial) cell lines.

Main Results:

• The synthesized rhodamine-Gd(III) complexes exhibited good selectivity for human glioma cells (T98G) over glial cells (SVG p12).
• All complexes demonstrated low cytotoxicity at effective concentrations.
• Superior tumor cell uptake was observed compared to previously reported rhodamine-lanthanoid(III) and Gd(III)-arylphosphonium complexes, with significant increases in Gd uptake.

Conclusions:

• Novel rhodamine-Gd(III) complexes possess promising properties for targeted cancer imaging.
• The enhanced cellular uptake and selectivity suggest potential applications in diagnostic imaging of gliomas.
• These findings warrant further investigation for in vivo efficacy and safety assessments.